![New Covid Variant Kp.3 On The Rise: Here'S What You Need To Know 2 73992276007](https://www.gannett-cdn.com/authoring/videos/videoelephant/thumbnails/73992276007.jpg)
FDA advisors recommend targeting the JN.1 strain for fall Covid vaccine recipes.
Government advisers say now is the time to update the formulation of the Covid-19 vaccines Americans will receive in the fall, targeting the JN.1 version.
Scripps News
of Centers for Disease Control and Prevention According to data, a new variant of Covid, the KP.3 variantIt is rising to dominance throughout the United States.
For the two-week period beginning May 26 and ending June 8, government agency data showed KP.3 accounted for 25% of all COVID cases in the U.S. and is now the dominant variant. This knocks off the previous lead of the JN.1 variant, which spread globally last summer and now accounts for 22.5% of cases.
CDC uses Nowcast data tracker To plan for covid variations in two weeks time. The tool is used to estimate the current spread of strains, but it does not predict future spread of the virus, the CDC said.
Could there be summer congestion? New variants of the Covid-19 FLiRT are now the main variant.
What is the difference between KP.3?
Same thread as JN.1 and “FLiRT” variants KP.1.1 and KP.2, KP.3.
USA TODAY contacted the CDC for more information on the mutation, but have not heard back.
Status of Covid cases in the US
Although mortality and hospitalization rates have decreased significantly, the data show that the cost of positive tests and emergency room visits is increasing.
The CDC recently reported on June 4 that “Covid-19 infections are increasing or increasing in 30 states.”
A covid vaccine will target JN.1.
The major emergence of the KP.3 variant comes at an FDA panel meeting this week to discuss an update on the fallout from the Covid vaccine.
Season Advisory Committee on Vaccines and Related Biological ProductsHealth experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel that they were preparing to offer vaccines targeting JN.1 in August, pending FDA approval.
Updated vaccines are set to be released in the fall ahead of an expected winter spike in Covid-19 cases.
Contributing: Eduardo Cuevas, USA TODAY.
Ahjane Forbes is a reporter on the national trending team at USA Today. Ahjane covers breaking news, car memorabilia, crime, health, lottery and public policy stories. Email her aforbes@gannett.com. Keep an eye on her. Instagram, Threads And X (Twitter).